Rituximab (Rituxan) | American Journal of Neuroradiology
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Rheumatoid arthritis - The Lancet
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
The Risk of Hyperglycaemia with the use of Rituximab in Rheumatoid Arthritis. Results from a Meta-analysis of Randomised Clinica
B-Cell Targeted Therapies: Clinical Trials Update
Biological Therapy for Rheumatoid Arthritis - ppt download
2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis | Reumatología Clínica
Empowering Targeted Therapy: Lessons from Rituximab | Science's STKE
Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
Rituximab - Wikipedia
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
New Drugs for Rheumatoid Arthritis | NEJM
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience | Annals of the Rheumatic Diseases
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
B-Cell Targeted Therapies: Clinical Trials Update
Rituximab-related Severe Toxicity | SpringerLink
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
Rituximab Use in Pediatric Dermatology - JDDonline - Journal of Drugs in Dermatology
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management | European Respiratory Society
